The FDA has granted approval to treatment with Tepylute, a ready-to-dilute version of thiotepa, at 100 mg for breast and ...

INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian ...

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...

Breast MRI helps doctors detect disease in newly diagnosed and high-risk patients without replacing mammograms, according to ...

Among patients with non-muscle-invasive bladder cancer (NMIBC), neoadjuvant treatment with mitomycin C prior to transurethral ...

Alternating between Glivec and Stivarga therapy didn't impact survival outcomes; it led to more toxicity and discontinuations in patients with GIST.

TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk ...

Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer ...

I reflect on how a generic mammogram reminder overlooked my experience as a breast cancer survivor and how thoughtful ...

Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for ...

Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate ...

When Jill decided to return to school to become an advanced practitioner, she sought my counsel. Going back to school after ...